Pharmacoeconomic component of a clinical trial conducted in Latin America: Conceptual and empirical considerations

International Journal of Technology Assessment in Health Care

Volumn 17, Issue 4, 2001, Pages 571-578

  Reinharz, Daniel ^a   Saldaña, Victor Raúl Zurita ^b   Follador, Wilson ^c   Asche, Carl ^d  

^a LAVAL UNIVERSITY   (Canada)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d SIMON FRASER UNIVERSITY   (Canada)

Author keywords

Latin America; Pharmacoeconomics

Indexed keywords

ARTICLE; CENTRAL AMERICA; CLINICAL RESEARCH; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HEALTH ECONOMICS; METHODOLOGY; OUTCOMES RESEARCH; QUALITY OF LIFE; SOUTH AMERICA;

EID: 0035192971     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0266462301107117     Document Type: Article

References (11)

1. Is academic medicine for sale?
2. Use of economic evaluation guidelines: 2 Years' experience in Canada
3. Uneasy alliance: Clinical investigators and the pharmaceutical industry
4. Centralised versus decentralised funding of evaluative research: Impact on medical technology policy in Italy
5. India promises to become a world centre for testing new medicines
6. The reform agenda for national civil service systems: External stress and internal strains
7. Capacity building in health economics: Opportunities for training in developing countries
8. Managed care arrives in Latin America
9. The exportation of managed care to Latin America